VERSARTIS
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders. It develops new therapeutic proteins utilizing the novel half-life extension technology, XTEN. Versartis owns and develops the novel drug candidates that it has licensed from Amunix. Headquartered in Redwood City, California, Versartis' lead program, VRS-317, has recently completed enrollment in a multi-center Phase 1 study in adult patients with growth hormone deficiency. The compan... y is staffed with drug development experts and utilizes external contract services to execute on its product development plans in a capital-efficient manner. The company was founded in December 2008 as a joint venture between Amunix Inc. and Index Ventures. The founders are Jeffrey Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman.
VERSARTIS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-12-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.versartis.co
Total Employee:
11+
Status:
Closed
Contact:
16509638598
Email Addresses:
[email protected]
Total Funding:
144.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS Microsoft Unified Layer Comcast Akamai Hosted
Similar Organizations
ORGANIC GENOMICS
ORGANIC GENOMICS is a biotechnology company for developing health care products of therapeutic proteins.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
New Leaf Venture Partners
New Leaf Venture Partners investment in Series E - Versartis
Aisling Capital
Aisling Capital investment in Series E - Versartis
Advent Life Sciences
Advent Life Sciences investment in Series E - Versartis
Sofinnova Investments
Sofinnova Investments investment in Series E - Versartis
Amunix
Amunix investment in Series D - Versartis
New Leaf Venture Partners
New Leaf Venture Partners investment in Series D - Versartis
Sofinnova Investments
Sofinnova Investments investment in Series D - Versartis
Aisling Capital
Aisling Capital investment in Series D - Versartis
Advent Venture Partners
Advent Venture Partners investment in Series D - Versartis
Index Ventures
Index Ventures investment in Series D - Versartis
Official Site Inspections
http://www.versartis.co
- Host name: box2407.bluehost.com
- IP address: 50.87.227.169
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
